| Recommended daily dose ranges | |
| Statins | |
|---|---|
| Atorvastatin | 10 mg-80 mg |
| Fluvastatin | 20 mg-80 mg |
| Lovastatin | 20 mg-80 mg |
| Pravastatin | 10 mg-40 mg |
| Rosuvastatin | 5 mg-40 mg |
| Simvastatin | 10 mg-80 mg* |
| Bile acid and/or cholesterol absorption inhibitors | |
| Cholestyramine | 2 g-24 g |
| Colestipol | 5 g-30 g |
| Colesevelam | 2.5 g-3.75 g |
| Ezetimibe | 10 mg |
| Fibrates | |
| Benzafibrate | 400 mg |
| Fenofibrate** | 48 mg-200 mg |
| Gemfibrozil**, *** | 600 mg-1200 mg |
| Niacin | |
| Nicotinic acid | 1 g-3 g / 0.5 g-2 g |
Note: The topic of nonstatin pharmacotherapy was not reviewed in detail and thus no new formal recommendations were presented in the 2012 guidelines.
*Increased myopathy on 80 mg, Simvastatin 80 mg has a higher incidence of rhabdomyolysis;
**Reduce dose or avoid in renal impairment;
***Should not be used with a statin because of an increased risk of rhabdomyolysis.